Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Hill

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 11, 2016
It's Personal: Achieving Optimal Busulfan Exposure for All PatientsBrian T Hill
Oncotargets and Therapy|September 15, 2015
Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemiaBrian T Hill, Matt Kalaycio
Leukemia & Lymphoma|October 14, 2011
Clinical implications of the molecular subtypes of diffuse large B-cell lymphomaBrian T Hill, John Sweetenham
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
One Size Does Not Fit All: Who Benefits From Maintenance After Frontline Therapy for Follicular Lymphoma?Mark Roschewski, Brian T Hill
Journal of Virology|December 23, 2004
Human N-myristoyltransferases form stable complexes with lentiviral nef and other viral and cellular substrate proteinsBrian T Hill, Jacek Skowronski
Expert Opinion on Biological Therapy|February 10, 2021
Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphomaAgrima Mian, Brian T Hill
Leukemia & Lymphoma|June 15, 2026
Beyond the dose: social determinants and treatment intensity in DLBCLZiad Abuhelwa, Brian T Hill
Expert Opinion on Biological Therapy|January 28, 2026
Long-term outcomes and late toxicities of CAR T-cell therapy in large B-cell lymphomaRafaella Litvin, Brian T Hill
Expert Review of Hematology|September 14, 2022
Upfront therapy for diffuse large B-cell lymphoma: looking beyond R-CHOPBrian T Hill, Brad Kahl
Current Hematologic Malignancy Reports|April 29, 2010
Acute myeloid leukemia: when to transplant in first complete remissionBrian T Hill, Edward A Copelan
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 11, 2016
It's Personal: Achieving Optimal Busulfan Exposure for All PatientsBrian T Hill
Oncotargets and Therapy|September 15, 2015
Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemiaBrian T Hill, Matt Kalaycio
Leukemia & Lymphoma|October 14, 2011
Clinical implications of the molecular subtypes of diffuse large B-cell lymphomaBrian T Hill, John Sweetenham
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
One Size Does Not Fit All: Who Benefits From Maintenance After Frontline Therapy for Follicular Lymphoma?Mark Roschewski, Brian T Hill
Journal of Virology|December 23, 2004
Human N-myristoyltransferases form stable complexes with lentiviral nef and other viral and cellular substrate proteinsBrian T Hill, Jacek Skowronski
Expert Opinion on Biological Therapy|February 10, 2021
Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphomaAgrima Mian, Brian T Hill
Leukemia & Lymphoma|June 15, 2026
Beyond the dose: social determinants and treatment intensity in DLBCLZiad Abuhelwa, Brian T Hill
Expert Opinion on Biological Therapy|January 28, 2026
Long-term outcomes and late toxicities of CAR T-cell therapy in large B-cell lymphomaRafaella Litvin, Brian T Hill
Expert Review of Hematology|September 14, 2022
Upfront therapy for diffuse large B-cell lymphoma: looking beyond R-CHOPBrian T Hill, Brad Kahl
Current Hematologic Malignancy Reports|April 29, 2010
Acute myeloid leukemia: when to transplant in first complete remissionBrian T Hill, Edward A Copelan
Pageof 17